Moonlake Immunotherapeutics · NASDAQ:MLTX

Reich Kristian sold 16,105 Moonlake Immunotherapeutics shares (Form 4)

Traded Jul 15, 2026 · Filed Jul 20, 2026

On Jul 15, 2026, Reich Kristian (Chief Scientific Officer) sold 16,105 Moonlake Immunotherapeutics shares at US$20.01 for US$322K under a trading plan, leaving 2,808,446 shares. Filed Jul 20, 2026 (Form 4).

Sold
16,105 shares
Price
US$20.01
Value
US$322K
Holding after
2,808,446 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 15, 2026Class A ordinary shares, par value $0.0001 per shareSale16,105US$20.012,808,446Indirect

Source

View original at SEC

Related